chr9-35683151-C-T

Variant names:

• chr9-35683151-C-T
• rs56249943
• NM_003289.4:c.*8G>A

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_Moderate BP6_Very_Strong BA1

The NM_003289.4(TPM2):​c.*8G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0855 in 1,552,166 control chromosomes in the GnomAD database, including 6,178 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.063 (372 hom., cov: 32)
  • Exomes 𝑓: 0.088 (5806 hom.)
• Consequence: TPM2 NM_003289.4 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:11 O:1
• Conservation: PhyloP100: -0.423

Genes affected

TPM2 (HGNC:12011): (tropomyosin 2) This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]

ACMG classification

Our verdict: Benign. The variant received -18 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.46).
• BP6: Variant 9-35683151-C-T is Benign according to our data. Variant chr9-35683151-C-T is described in ClinVar as [Benign]. Clinvar id is 94122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-35683151-C-T is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0915 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TPM2	NM_003289.4	c.*8G>A		3_prime_UTR_variant	Exon 9 of 9	ENST00000645482.3	NP_003280.2
TPM2	NM_001301227.2	c.*8G>A		3_prime_UTR_variant	Exon 9 of 9		NP_001288156.1
TPM2	NM_001301226.2	c.773-988G>A		intron_variant	Intron 8 of 8		NP_001288155.1
TPM2	NM_213674.1	c.773-988G>A		intron_variant	Intron 8 of 8		NP_998839.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TPM2	ENST00000645482	c.*8G>A		3_prime_UTR_variant	Exon 9 of 9		NM_003289.4	ENSP00000496494.2

Frequencies

GnomAD3 genomes AF: 0.0632 AC: 9609 AN: 152014 Hom.: 372 Cov.: 32

Gnomad AFR AF: 0.0148

Gnomad AMI AF: 0.239

Gnomad AMR AF: 0.0650

Gnomad ASJ AF: 0.0859

Gnomad EAS AF: 0.0284

Gnomad SAS AF: 0.0759

Gnomad FIN AF: 0.0418

Gnomad MID AF: 0.127

Gnomad NFE AF: 0.0934

Gnomad OTH AF: 0.0692

GnomAD2 exomes AF: 0.0760 AC: 12096 AN: 159072 AF XY: 0.0785

Gnomad AFR exome AF: 0.0138

Gnomad AMR exome AF: 0.0717

Gnomad ASJ exome AF: 0.0904

Gnomad EAS exome AF: 0.0327

Gnomad FIN exome AF: 0.0460

Gnomad NFE exome AF: 0.0976

Gnomad OTH exome AF: 0.0762

GnomAD4 exome AF: 0.0879 AC: 123047 AN: 1400034 Hom.: 5806 Cov.: 33 AF XY: 0.0885 AC XY: 61092 AN XY: 690674

Gnomad4 AFR exome AF: 0.0139 AC: 440 AN: 31602

Gnomad4 AMR exome AF: 0.0701 AC: 2518 AN: 35896

Gnomad4 ASJ exome AF: 0.0883 AC: 2229 AN: 25246

Gnomad4 EAS exome AF: 0.0215 AC: 769 AN: 35818

Gnomad4 SAS exome AF: 0.0840 AC: 6669 AN: 79426

Gnomad4 FIN exome AF: 0.0466 AC: 2295 AN: 49282

Gnomad4 NFE exome AF: 0.0953 AC: 102860 AN: 1079032

Gnomad4 Remaining exome AF: 0.0837 AC: 4855 AN: 58034

GnomAD4 genome AF: 0.0632 AC: 9614 AN: 152132 Hom.: 372 Cov.: 32 AF XY: 0.0608 AC XY: 4525 AN XY: 74402

Gnomad4 AFR AF: 0.0147 AC: 0.0146889 AN: 0.0146889

Gnomad4 AMR AF: 0.0650 AC: 0.0650183 AN: 0.0650183

Gnomad4 ASJ AF: 0.0859 AC: 0.0859285 AN: 0.0859285

Gnomad4 EAS AF: 0.0285 AC: 0.0284884 AN: 0.0284884

Gnomad4 SAS AF: 0.0757 AC: 0.0757261 AN: 0.0757261

Gnomad4 FIN AF: 0.0418 AC: 0.0418319 AN: 0.0418319

Gnomad4 NFE AF: 0.0935 AC: 0.0934575 AN: 0.0934575

Gnomad4 OTH AF: 0.0704 AC: 0.0704159 AN: 0.0704159

Alfa AF: 0.0851 Hom.: 281

Bravo AF: 0.0653

Asia WGS AF: 0.0620 AC: 216 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:11 Other:1

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not specified Benign:8

-

PreventionGenetics, part of Exact Sciences

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 16, 2013

Eurofins Ntd Llc (ga)

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Nov 24, 2014

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

*8G>A in exon 9A of TPM2: This variant is not expected to have clinical signific ance because it has been identified in 8.9% (757/8480) of European American chro mosomes from a broad population by the NHLBI Exome Sequencing Project (http://ev s.gs.washington.edu/EVS; dbSNP rs56249943). -

-

Genome Diagnostics Laboratory, University Medical Center Utrecht

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Aug 15, 2013

Genetic Services Laboratory, University of Chicago

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

-

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

-

Clinical Genetics, Academic Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Jan 29, 2016

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1 Other:1

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

-

TPM2 homepage - Leiden Muscular Dystrophy pages

Significance: not provided

Review Status: no classification provided

Collection Method: literature only

- -

Arthrogryposis, distal, type 1A Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Congenital myopathy 23 Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.46
CADD	Benign	0.65
DANN	Benign	0.85
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs56249943; hg19: chr9-35683148;